 |
| Pancreaticcanceristhefourth leADIngcauseofcancer-relateddeathintheUnitedStates.Withapredictedfive-yearrelativesurvivalrateoflessthan6%,pancreaticcancercontinuestobeclinicallychallengingduetoitsresistancetoeventhemostaggressivecombinationsofchemotherapyandradiotherapy.BecauseofindistinctsymptomsandtheabsenceofreliablediagnosticbioMarkers,diagnosesofpancreaticcancerareusuallydelayedandpatientprognosesarethereforegenerallypoor. |
| |
| DespiteextensiveresearchtounderstandthemolecularmechanismsunderlyingpancreatictumOrigenesis,muchremainstobelearned.Recentresearchhashighlightedtheimportanceofseveralnewtherapeutictargets,andwiththisinformation,novelapproachestosignificantlyimprovetheclinicaloutcomeofpancreaticcancerhavebeendescribedincludingdisruptionofdownstreamsignalingcascades,anti-angiogenesistherapies,anddiscoveryofnewserumbiomarkers. |
| |
| GeneTexproudlyoffersalargeselectionofhigh-qualityantibodiesforpancreaticcancerresearch.OurpanelofhighlyspecificandsensitivereagentsincludesantibodiesagainstALCAM,BRCA2,CA19-9,COX1,COX2,ICAM1,IGFBP4,LCN2,Mesothelin,OCT2,OPG,PBX1,REG1A,REGIIIα,SMAD4,TIMP1andValosin-containingprotein(VCP),manyofwhicharevalidatedformultipleapplications.Pleaseseebelowtoviewourlargepanelofpancreaticcancer-relatedantibodiesandconsiderwhetherthesereagentscanhelpaccelerateyourresearch. |
| |
| |
| SelectPancreaticCancerAntibodies |
| |
ALCAM&ICAM1 | BRCA2 | COX1&COX2 | Mesothelin | OCT2 | OPG | PBX1 | REG1A®IIIα | SMAD4 | TIMP1 | Valosin-containingprotein(VCP) |
| |
| ALCAM&ICAM1Antibodies |
|
 | |  | |  | | ALCAM/CD166antibody[EPR2759(2)](GTX62567) | | ALCAM/CD166antibody[EPR2759(2)](GTX62567) | | ALCAMantibody[10FG12](GTX83191) |
|
 | |  | | | | ICAM1antibody[MEM-111](GTX22213) | | ICAM-1antibody[EPR4776],C-term(GTX62947) | | |
|
| |
| BRCA2Antibodies |
|
 | |  | |  | | BRCA2antibody[9D3](GTX70119) | | BRCA2antibody[3E6](GTX70121) | | BRCA2antibody[5F6](GTX70123) |
|
| |
| COX1&COX2Antibodies |
|
 | |  | |  | | COX1/Cyclooxygenase1antibody[EPR5866](GTX63375) | | COX1/Cyclooxygenase1antibody[EPR5866](GTX63375) | | COX1/Cyclooxygenase1antibody[EPR5867](GTX63493) |
|
 | |  | |  | | COX1/Cyclooxygenase1antibody[EPR5867](GTX63493) | | COX2antibody(GTX15191) | | COX2antibody(GTX73852) |
|
| |
| MesothelinAntibodies |
|
 | |  | |  | | Mesothelinantibody[N1C2](GTX105471) | | Mesothelinantibody[N1C2](GTX105471) | | Mesothelinantibody[EPR2685(2)](GTX62903) |
|
 | | | | | | Mesothelinantibody[EPR2685(2)](GTX62903) | | | | |
|
| |
| OCT2Antibodies |
|
 | |  | |  | | Oct-2antibody(GTX61216) | | Oct-2antibody(GTX61216) | | OCT2antibody[EPR542](GTX62219) |
|
 | | | | | | OCT2antibody[EPR542](GTX62219) | | | | |
|
| |
| OPGAntibodies |
|
 | |  | | | | OPGantibody(GTX127948) | | OPGantibody(GTX127948) | | |
|
| |
| PBX1Antibodies |
|
 | |  | | | | PBX1antibody(GTX113242) | | PBX1antibody,Internal(GTX88088) | | |
|
| |
| REG1A®IIIαAntibodies |
|
 | |  | | | | REG1Aantibody[1A4](GTX83376) | | REGIIIalphaantibody[C1C3](GTX108275) | | |
|
| |
| SMAD4Antibodies |
|
 | |  | |  | | SMAD4antibody(GTX112980) | | SMAD4antibody(GTX112980) | | SMAD4antibody[4G1C6](GTX82787) |
|
 | |  | | | | SMAD4antibody[4G1C6](GTX82787) | | SMAD4antibody[EP618Y],C-term(GTX61305) | | |
|
| |
| TIMP1Antibodies |
|
 | |  | |  | | TIMP1antibody(GTX112096) | | TIMP1antibody(GTX112096) | | TIMP1antibody[102D1](GTX21827) |
|
| |
| Valosin-containingprotein(VCP)Antibodies |
|
 | |  | |  | | VCPantibody[N1N2],N-term(GTX113030) | | VCPantibody[N3C2],Internal(GTX113099) | | VCPantibody[EPR3307(2)](GTX62809) |
|
| |
| |
| |
